Aims To estimate the association of smoking status with rates of (i) infection,(ii)
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …

Abstract Background Coronavirus disease 2019 (COVID-19) has evolved into a worldwide
pandemic, and has been found to be closely associated with mental and neurological …

Background Mental disorders might be a risk factor for severe COVID-19. We aimed to
assess the specific risks of COVID-19-related mortality, hospitalisation, and intensive care …

Objective Individuals with schizophrenia may be at an increased risk for COVID-19 morbidity
due to the disease characteristics. In this study, we aimed to explore the odds of significant …

A COVID-19 patient often presents with multiple comorbidities and is associated with
adverse outcomes. A comprehensive assessment of the prevalence of comorbidities in …

Background: Increasing clinical evidence suggests that people with severe mental illness
(SMI), including schizophrenia spectrum disorders, bipolar disorder (BD), and major …

Clinicians should inform and educate their patients on the risks related to SARS-CoV-2
infection and COVID-19 and on the precautions that they should adopt to avoid contagion …

Long COVID refers to the lingering symptoms which persist or appear after the acute illness.
The dominant long COVID symptoms in the two years since the pandemic began (2020 …

Objective Schizophrenia has been associated with patients' poor quality of life, disability,
and hospitalization. As of today, evidence that highlights the association between …

Importance Few studies have used precise age-specific data to construct age-standardized
estimates of the relative risks (RRs) of COVID-19 mortality for people experiencing …